The Medical Advisor

Abstract   Pancreatic cancer remains one of the most lethal malignancies, often diagnosed at advanced stages with limited treatment options. Recent studies and anecdotal reports suggest that repurposed drugs and alternative therapies may offer new hope for improving patient outcomes. This review examines emerging evidence on ivermectin, fenbendazole, high-dose vitamin C, and hydroxychloroquine as potential adjunct therapeutic agents for pancreatic cancer. While preliminary findings are promising, further clinical trials are necessary to establish their efficacy and safety. Keywords: Pancreatic cancer, ivermectin, fenbendazole, vitamin D, hydroxychloroquine, repurposed drugs, chemotherapy, high-dose vitamin C, immunotherapy Pancreatic Cancer Awareness 1. Introduction   Approaches to improve pancreatic cancer therapy are essential as this disease has a very bleak outcome. Appr...

Can supplements influence cancer risk? Dive into 1,000+ research studies to find out.   Current AI tools like ChatGPT, Gemini from Google and Copilot from Microsoft might return generic answers to your questions. While these can be a starting point, they often lack the depth you might crave. The term  " anti-cancer supplements "  can be misleading. While some nutrients  support the body  in cancer prevention or treatment, others may  interfere with therapies  or even pose risks. Certain bioactive compounds, found in foods, are known to have strong epigenetic (cancer correcting) benefits. Supplements concentrate those benefits. We are not going to recommend you take a multivitamin and mineral if you already have the disease. Why? because the vitamins are usually synthetic and deficient, and the minerals include iron, which is known to help cancer cells thrive. While your cancer specialist or oncologist may not dive deeply into s...